×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| TORRENT PHARMACEUTICALS LTD. | 26110.0 | 5510.0 | 26160.0 | 16.28 | 1,21,637 | 60.2 |
| APOLLO HOSPITALS ENTERPRISE LT | 22004.0 | 3069.0 | 21679.0 | 21.35 | 112412 | 71.4 |
| Max Healthcare Institute Limit | 7738.7 | 1660.3 | 6940.2 | 1.7 | 111767 | 93.2 |
Torrent Pharmaceuticals Ltd., with Security Code 500420, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,920.0 | 2,121.0 | 2,146.0 | 2,123.0 | 2,143.0 | 2,438.0 | 2,434.0 | 2,377.0 | 2,433.0 | 2,616.0 |
| Expenses | 1,342.0 | 1,384.0 | 1,410.0 | 1,422.0 | 1,427.0 | 1,539.0 | 1,513.0 | 1,490.0 | 1,565.0 | 1,637.0 |
| Operating Profit | 578.0 | 737.0 | 736.0 | 701.0 | 716.0 | 899.0 | 921.0 | 887.0 | 868.0 | 979.0 |
| OPM % | 30.1% | 34.75% | 34.3% | 33.02% | 33.41% | 36.87% | 37.84% | 37.32% | 35.68% | 37.42% |
| Other Income | 26.0 | 11.0 | 15.0 | -11.0 | 76.0 | 21.0 | -7.0 | 3.0 | -9.0 | -5.0 |
| Interest | 94.0 | 90.0 | 77.0 | 69.0 | 67.0 | 64.0 | 54.0 | 48.0 | 47.0 | 45.0 |
| Depreciation | 182.0 | 183.0 | 192.0 | 191.0 | 195.0 | 189.0 | 190.0 | 191.0 | 190.0 | 187.0 |
| Profit before tax | 328.0 | 475.0 | 482.0 | 430.0 | 530.0 | 667.0 | 670.0 | 651.0 | 646.0 | 742.0 |
| Tax % | -33.2% | -32% | -32.2% | -30.9% | -22.6% | 29.7% | -31.3% | -25.5% | -23.8% | 25.7% |
| Net Profit | 219.0 | 323.0 | 327.0 | 297.0 | 410.0 | 469.0 | 460.0 | 485.0 | 474.0 | 551.0 |
| EPS in Rs | 6.46 | 9.55 | 9.65 | 8.78 | 12.12 | 13.86 | 13.6 | 14.33 | 0 | 16.28 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,491.0 | 2,491.0 | 2,591.0 | 2,660.0 | 2,732.0 | 2,745.0 | 2,859.0 | 2,889.0 | 2,809.0 | 2,959.0 |
| Expenses | 1,767.0 | 1,764.0 | 1,800.0 | 1,835.0 | 1,863.0 | 1,862.0 | 1,955.0 | 1,950.0 | 1,895.0 | 1,995.0 |
| Operating Profit | 724.0 | 727.0 | 791.0 | 825.0 | 869.0 | 883.0 | 904.0 | 939.0 | 914.0 | 964.0 |
| OPM % | 29.06% | 29.19% | 30.53% | 31.02% | 31.81% | 32.17% | 31.62% | 32.5% | 32.54% | 32.58% |
| Other Income | -10.0 | 9.0 | 34.0 | 26.0 | 55.0 | 31.0 | 24.0 | -16.0 | 33.0 | -42.0 |
| Interest | 102.0 | 107.0 | 103.0 | 91.0 | 80.0 | 80.0 | 75.0 | 64.0 | 57.0 | 56.0 |
| Depreciation | 193.0 | 196.0 | 191.0 | 201.0 | 213.0 | 203.0 | 197.0 | 198.0 | 199.0 | 201.0 |
| Profit before tax | 419.0 | 433.0 | 531.0 | 559.0 | 543.0 | 631.0 | 656.0 | 661.0 | 691.0 | 689.0 |
| Tax % | -32.5% | -33.7% | -28.8% | -30.9% | -29.8% | -28.8% | -30.3% | 31.5% | 27.2% | -25.1% |
| Net Profit | 283.0 | 287.0 | 378.0 | 386.0 | 443.0 | 449.0 | 457.0 | 453.0 | 503.0 | 498.0 |
| EPS in Rs | 8.36 | 8.48 | 11.18 | 11.39 | 13.1 | 13.27 | 13.51 | 13.37 | 14.88 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 25% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 35% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | 11% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 21% |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 35% |
| 1 Year: | 19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|